CytoReason expands deal with Sanofi to look at IBD
CytoReason, which creates computational disease modeling, has announced an expansion of its collaboration with Sanofi.…
January 24, 2023 - 2 minutes
CytoReason
CytoReason and Pfizer agree deal worth up to $110M for AI drug discovery and development
In a deal with a potential value of $110 million over the next five years,…
September 20, 2022 - 3 minutes
